Log In
Monday 26th August 2019

Heads of research removed from AstraZeneca

16th January 2013

AstraZeneca’s new chief executive Pascal Soriot has made changes to the management structure of Britain’s second biggest pharmaceutical company.

Soriot, who took over in October, has removed the heads of research and commercial operations – Martin Mackay and Tony Zook - in a management revamp designed to speed decision-making, with both men leaving the company at the end of January. They will be replaced by three senior research and development roles, while on the commercial side of the company three positions will represent different regions.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019